AVAL
Grupo Aval Acciones y Valores S.A.
There isn't enough reported data to score AVAL yet.
BAC
Bank of America Corporation
BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.
AVAL Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
AVAL's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AVAL.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
AVAL PE Valuation
AVAL has no meaningful PE right now: it lost money over the past year.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
AVAL Forward outlook
There aren't enough analyst estimates for AVAL to show an outlook.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
AVAL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.44 | +10% |
| Q1 2026 | $0.43 | +34% |
| Q4 2025 | $0.44 | +69% |
| Q3 2025 | $0.42 | +100% |
| Q2 2025 | $0.40 | +233% |
| Q1 2025 | $0.32 | +191% |
| Q4 2024 | $0.26 | +44% |
| Q3 2024 | $0.21 | +163% |
AVAL has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
AVAL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $3.5B | +25% |
| Q1 2026 | $2.9B | +7.6% |
| Q4 2025 | $3.5B | +31% |
| Q3 2025 | $2.8B | +0.6% |
| Q2 2025 | $2.8B | +0.7% |
| Q1 2025 | $2.7B | -6.1% |
| Q4 2024 | $2.7B | -9.1% |
| Q3 2024 | $2.8B | -0.8% |
AVAL's revenue has grown year over year for five quarters in a row: $3.5B last quarter, up 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 11% | -2.3 points |
| Q1 2026 | 14% | +0.8 points |
| Q4 2025 | 9.4% | +2.5 points |
| Q3 2025 | 13% | +1.8 points |
| Q2 2025 | 14% | +5.4 points |
| Q1 2025 | 13% | +5.8 points |
| Q4 2024 | 6.9% | +0.5 points |
| Q3 2024 | 11% | +6.4 points |
AVAL's operating margin was 11% last quarter, down 2.3 points from the same quarter a year ago.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over AVAL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over AVAL on profitability, with a higher operating margin.
AVAL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $612.6M | +80% |
| Q1 2026 | -$32.5M | -136% |
| Q4 2025 | -$342.6M | +$627.2M |
| Q3 2025 | $394.5M | +81% |
| Q2 2025 | $339.9M | +$2.7B |
| Q1 2025 | $89.7M | +$1.4B |
| Q4 2024 | -$969.8M | -$494.2M |
| Q3 2024 | $217.7M | +223% |
AVAL has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
AVAL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | +13 shares |
| 5 years | +6.6% | +73.1M shares |
| Available history | +6.6% | +73.1M shares |
AVAL has 1.2B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $16.7M |
| Q3 2024 | — |
AVAL hasn't bought back shares in the past year.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over AVAL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
AVAL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 8.6x | High |
| Q1 2026 | 7.3x | High |
| Q4 2025 | 9.2x | High |
| Q3 2025 | 11.5x | High |
| Q2 2025 | 10.3x | High |
| Q1 2025 | 11.4x | High |
| Q4 2024 | 14.5x | High |
| Q3 2024 | 13.5x | High |
AVAL's net debt is about 8.6 years of its operating earnings (EBITDA), down from 10 years a year ago. Net leverage isn't a meaningful measure for financial services companies like AVAL.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC has the edge over AVAL on leverage, with a lower net debt burden relative to earnings.
AVAL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.9 | Neutral |
| Stochastic | 5.3 | Oversold |
AVAL's weekly RSI is 35 (neutral) and its Stochastic is 5 (oversold).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
AVAL PE vs Financial Services Sector
AVAL has no meaningful PE right now: it lost money over the past year.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
AVAL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.63 | 15% below |
| 20 week MA | $4.95 | 20% below |
| 50 week MA | $4.65 | 15% below |
| 100 week MA | $3.83 | 3.1% above |
| 200 week MA | $3.07 | 29% above |
AVAL has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
AVAL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.72 | $6.86 | -21% |
| 2021 | $6.86 | $5.24 | -24% |
| 2022 | $5.24 | $2.33 | -56% |
| 2023 | $2.33 | $2.43 | +4.3% |
| 2024 | $2.43 | $2.07 | -15% |
| 2025 | $2.07 | $4.23 | +104% |
| 2026 YTD | $4.23 | $3.95 | -6.6% |
AVAL has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.